Development of Normal and Tumor Organoids from Bloom Syndrome to Evaluate Responses to Pharmacological and Genetic Perturbations

Awardee: Nathan Ellis

Institution: University of Arizona

Awarded: $150,000

Funding Period: September 1, 2022 - August 31, 2024

Previous
Previous

Identification and characterization of factors that suppress Bloom syndrome genomic instability

Next
Next

Multi-organ Gene Therapy for Bloom Syndrome